<DOC>
	<DOCNO>NCT01744730</DOCNO>
	<brief_summary>The purpose study well understand clindamycin work child fall 85th percentile high body mass index ( BMI - ratio weight height ) . The result study help good understand child higher BMI range process medication differently whether dose adjusted child .</brief_summary>
	<brief_title>Safety Pharmacokinetics Clindamycin Pediatric Subjects With BMI ≥ 85th Percentile</brief_title>
	<detailed_description>This prospective , open-label pharmacokinetic safety study multiple dos IV oral clindamycin overweight obese child age 2 17 year age . The total study duration expect approximately 24 month ; subject participate study 18 day ( screen day ; treatment day 1-14 [ may short 2 day ] followed observation period 3 day post discontinuation clindamycin therapy day 17 ( day 18 ) therapy treat 14 day clindamycin ) .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<criteria>2 year &lt; 18 year age time first dose study drug Suspected confirm infection OR receive IV clindamycin per routine care Negative serum pregnancy test ( female reach menarche ) within 24 hour first dose study drug agreement practice appropriate contraceptive measure , include abstinence , time initial pregnancy test last dose study drug BMI ≥ 85th percentile age sex , base Centers Disease Control ( CDC ) recommendation Signed informed consent/Health Insurance Portability Accountability Act ( HIPAA ) document parent/legal guardian assent ( applicable ) The follow apply NOT already receive clindamycin per routine care : 1 . History hypersensitivity allergic reaction clindamycin lincomycin 2 . History C. difficile colitis previous administration clindamycin 3 . Aspartate aminotransferase ( AST ) &gt; 120 units/L 4 . Alanine aminotransferase ( ALT ) &gt; 210 units/L 5 . Total bilirubin &gt; 3 mg/dL 6 . Serum creatinine &gt; 2 mg/dL 7 . Receiving neuromuscular blocker part therapy Previous participation study Subject prohibit medication herbal product ( see Appendix II ) Subject receive extracorporeal life support ( ECLS ) Subject postcardiac bypass ( within 24 hour ) Subject inotropes/pressors Any condition chronic illness , opinion principal investigator , make participation unadvised unsafe</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bacterial infection</keyword>
	<keyword>Obesity</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>clindamycin</keyword>
</DOC>